...
首页> 外文期刊>Prion >Poly-L-histidine inhibits prion propagation in a prion-infected cell line
【24h】

Poly-L-histidine inhibits prion propagation in a prion-infected cell line

机译:多L-组氨酸抑制朊病毒感染细胞系中的朊病毒繁殖

获取原文
获取原文并翻译 | 示例
           

摘要

Transmissible spongiform encephalopathies (TSEs) are a group of lethal neurodegenerative diseases involving the structural conversion of cellular prion protein (PrPC) into the pathogenic isoform (PrPSc) for which no effective treatment is currently available. Previous studies have implicated that a polymeric molecule with a repeating unit, such as pentosane polysulfate and polyamidoamide dendrimers, exhibits a potent anti-prion activity, suggesting that poly-(amino acid)s could be a candidate molecule for inhibiting prion propagation. Here, by screening a series of poly-(amino acid)s in a prion-infected neuroblastoma cell line (GT(FK)), we identified poly-L-His as a novel anti-prion compound with an IC50 value of 1.8 mu g/mL (0.18 mu M). This potent anti-prion activity was specific to a high-molecular-weight poly-L-His and absent in monomeric histidine or low-molecular-weight poly-L-His. Solution NMR data indicated that poly-L-His directly binds to the loop region connecting Helix 2 and Helix 3 of PrPC and sterically blocks the structural conversion toward PrPSc. Poly-L-His, however, did not inhibit prion propagation in a prion-infected mouse when administered intraperitoneally, suggesting that the penetration of blood-brain barrier and/or the chemical stability of this polypeptide must be addressed before its application in vivo. Taken together, this study revealed the potential use of poly-L-His as a novel treatment against TSEs. (203 words)
机译:传染性海绵状脑病(TSEs)是一组致命的神经退行性疾病,涉及细胞朊蛋白(PrPC)向致病性亚型(PrPSc)的结构转换,目前尚无有效的治疗方法。先前的研究表明,具有重复单元的聚合物分子,如戊聚糖多硫酸盐和聚酰胺酰胺树状大分子,具有强大的抗朊病毒活性,表明聚(氨基酸)s可能是抑制朊病毒传播的候选分子。在这里,通过在朊病毒感染的神经母细胞瘤细胞系(GT(FK))中筛选一系列多聚氨基酸,我们确定了聚-L-His是一种新型的抗朊病毒化合物,IC50值为1.8μg/mL(0.18μM)。这种有效的抗朊病毒活性特异于高分子量聚-L-His,在单体组氨酸或低分子量聚-L-His中不存在。溶液核磁共振数据表明,聚-L-His直接结合到连接PrPC螺旋2和螺旋3的环区,并在空间上阻止结构向PrPSc的转化。然而,经腹腔注射的Poly-L-His并不能抑制朊病毒感染小鼠体内的朊病毒繁殖,这表明在将其应用于体内之前,必须解决血脑屏障的穿透和/或这种多肽的化学稳定性问题。综上所述,这项研究揭示了聚-L-His作为一种新型治疗TSEs的潜在用途。(203字)

著录项

  • 来源
    《Prion》 |2018年第4期|共8页
  • 作者单位

    Gifu Univ United Grad Sch Drug Discovery &

    Med Informat Sci Gifu Japan;

    Osaka Univ Inst Prot Res Osaka Japan;

    Gifu Univ United Grad Sch Drug Discovery &

    Med Informat Sci Gifu Japan;

    Gifu Univ United Grad Sch Drug Discovery &

    Med Informat Sci Gifu Japan;

    Gifu Univ United Grad Sch Drug Discovery &

    Med Informat Sci Gifu Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 基础医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号